You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

depsipeptide

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Small Cell, NSCLC, Esophageal Tumors Trial run by the NCI (Depsipeptide, Flavopiridol (alvocidib))

Terminated
  • Carcinoma, Small Cell
  • +3 more
  • Depsipeptide
  • Flavopiridol (alvocidib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019

Advanced Esophageal Cancers, Primary Small Cell Lung Cancers, Non-Small-Cell Lung Carcinoma Trial run by the NCI (Decitabine,

Completed
  • Advanced Esophageal Cancers
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 27, 2019

Malignant Melanoma, Melanoma Trial (Depsipeptide)

Terminated
Has Results
  • Malignant Melanoma
  • Melanoma
  • Depsipeptide
  • (no location specified)
Feb 1, 2016

Ovarian Cancer Trial in Maywood (depsipeptide)

Withdrawn
  • Ovarian Cancer
  • depsipeptide
  • Maywood, Illinois
    Cardinal Bernardin Cancer Center at Loyola University Medical Ce
Sep 4, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial (Depsipeptide)

Terminated
  • Bladder Cancer
  • +2 more
  • Depsipeptide
  • (no location specified)
Oct 31, 2012

Multiple Myeloma Trial in Melbourne (depsipeptide, bortezomib, dexamethasone)

Unknown status
  • Multiple Myeloma
  • depsipeptide
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2011

Peripheral T Cell Lymphoma (PTCL) Trial (Depsipeptide)

Unknown status
  • Peripheral T Cell Lymphoma (PTCL)
  • Depsipeptide
  • (no location specified)
Mar 3, 2006